Labshake search
Citations for R&D Systems :
801 - 850 of 1684 citations for 3 2 5 Dioxoimidazolidin 4 yl propanoic acid since 2020
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
RORγt-dependent antigen-presenting cells direct regulatory T cell-mediated tolerance to food antigenbioRxiv - Immunology 2024Quote: ... cells were stimulated ex vivo for 3 h with IL-23 (10 ng/mL; R&D systems) and GolgiStop (BD Biosciences ...
-
bioRxiv - Cell Biology 2020Quote: ... and HHIP (Cat#9280-HP-050; R&D Systems; used 5 μg/mL) were added to the media after 48 hours and replenished in every media change ...
-
bioRxiv - Neuroscience 2020Quote: ... and 5 ng/mL of basic fibroblast growth factor (bFGF; R&D Systems) on 0.1% gelatin coated dishes with irradiated mouse embryonic fibroblast (iMEFs).
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D Systems, Minneapolis, MN, USA) and antibiotics/antimycotics (ThermoFisher Scientific ...
-
bioRxiv - Bioengineering 2021Quote: ... Wnt was inactivated by adding XAV939 (5 μmol/L, R&D Systems 3748) in BPEL ...
-
bioRxiv - Cell Biology 2021Quote: ... and 5 ng/mL TGF-β (R&D Systems, cat# 240-B-002). To test the effect of FYN depletion on collagen deposition ...
-
bioRxiv - Microbiology 2021Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D Systems, Minneapolis, MN, USA) and antibiotics/antimycotics (ThermoFisher Scientific ...
-
bioRxiv - Bioengineering 2021Quote: ... Wnt was inactivated by adding XAV939 (5 μmol/L, R&D Systems 3748) in BPEL ...
-
bioRxiv - Microbiology 2020Quote: ... supplemented with 5% fetal bovine serum (FBS, R&D Systems, Minneapolis, MN, USA) and antibiotics/antimycotics (Fisher Scientific ...
-
bioRxiv - Immunology 2020Quote: ... injection of AMD3100 (5 mg/kg in 200 µl saline; R&D Systems) were used to stimulate acute inflammation in the cremaster muscle and to mobilize neutrophils ...
-
bioRxiv - Immunology 2022Quote: ... and 5 ng/ml TGF-β1 (R&D Systems, Bio-Techne, Wiesbaden, Germany) for 72 hours.
-
bioRxiv - Cancer Biology 2022Quote: ... 5 μg/mL Tenascin-C (Cat no. 3358-TC-050, R&D Systems) coated ...
-
bioRxiv - Cancer Biology 2023Quote: ... 5 µg control IgG or anti-LRG1 antibodies (both from R&D Systems) were added to 500 μl of 3X CM (1000 μg total proteins ...
-
bioRxiv - Biophysics 2023Quote: ... 5 ng/ml of recombinant mouse interleukin-1β (IL-1β, R&D Systems), and 100 ng/ml of recombinant mouse interferon-γ (IFN-γ ...
-
bioRxiv - Bioengineering 2023Quote: ECFCs and PRECs were treated with 5 nM Fc Chimera (R&D Systems) or 100 ug/mL NRP-1 Antibody (R&D Systems ...
-
bioRxiv - Cell Biology 2024Quote: ... or recombinant FGF9 (5-25 ng/ml, R&D Systems, INC, Minneapolis, MN). After 24 ...
-
bioRxiv - Bioengineering 2024Quote: ... 5 ng/mL R-Spondin1 (R-spo1; R&D systems; 4645-RS/CF), and 1% B27 supplement (Gibco ...
-
bioRxiv - Developmental Biology 2024Quote: ... cultures were maintained in media containing 5 ng/ml FGF2 (R&D Systems), 15 ng/ml VEGF (Peprotech) ...
-
bioRxiv - Cell Biology 2024Quote: ... Primary antibodies used: mouse monoclonal anti-hSiglec-5 (R&D systems, 1:1000), rabbit anti-VCAM-1 polyclonal antibody (Santa Cruz ...
-
bioRxiv - Cell Biology 2024Quote: ... 5% BSA and VisUBlock Mouse on Mouse Blocking Reagent (R&D Systems, VB001). Primary and secondary antibodies were diluted in 0.1% saponin ...
-
bioRxiv - Immunology 2023Quote: ... Subsequently the cells were rested and expanded in kool aid complete media for 2 days supplemented with 100 U/mL recombinant Human IL-2 (R&D Systems Cat# 202-IL-010/CF). Subsequently ...
-
bioRxiv - Bioengineering 2024Quote: ... PBMCs were stimulated for 2 days with anti-CD3/anti-CD28 T cell activation beads (Thermo, catalog no. 11131D) in the presence of interleukin-2 (IL-2; 40 IU/ml; R&D Systems, catalog no. 202-IL-010) in complete T cell media and incubated at 37°C ...
-
bioRxiv - Microbiology 2020Quote: ... cells were pre-treated with IL-4 (200 U/ml) (R&D Systems, Minneapolis, MN) for 12h at 37°C and then stimulated and infected as above ...
-
bioRxiv - Cell Biology 2021Quote: ... and 4 mg/ml Collagen-I (Cultrex 3D rat tail collagen-I, R&D systems) on ice ...
-
bioRxiv - Immunology 2023Quote: ... and 25ng/ml recombinant mouse IL-4 (clone 404-ML-025/CF; R&D System) in final volume of 200 μl of RPMI 1640 medium supplemented with 10% FBS ...
-
bioRxiv - Cell Biology 2024Quote: ... and 50 ng/mL bone morphogenetic protein 4 (BMP4; 314-BP, R&D Systems, USA) on day 1 ...
-
bioRxiv - Neuroscience 2022Quote: ... followed by 4 hour incubation with mouse anti-O4 IgM (1:1000; R&D Systems) and rat anti-MBP (1:500 ...
-
bioRxiv - Immunology 2023Quote: ... 2.5% HEPES and stimulated with 50ng/ml IL-4 (R&D Systems Cat: 404-ML) for 15 minutes at 37°C ...
-
bioRxiv - Neuroscience 2023Quote: ... a 10 μL intramuscular injection of Spp1 neutralizing antibody (4 μg, AF808, R&D Systems) was administered into the tibialis anterior (TA ...
-
bioRxiv - Microbiology 2021Quote: ... cells were maintained in SFD media supplemented with the following: 3 μM CHIR 99021 (CHIR, R&D Systems), 10 ng/ml human FGF10 ...
-
bioRxiv - Cell Biology 2023Quote: ... after which the cells were exposed for 3 days to 200 ng/ml FGF-9 (R&D systems) and 1μg/mL heparin (Sigma Aldrich ...
-
bioRxiv - Neuroscience 2023Quote: ... explants were incubated overnight in PBS 3% BSA with primary antibody: anti-Robo1 (R&D Systems, 1:400) or anti-Robo2 (gift from Dr Alain Chédotal 53 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 100 U/mL rmIL-2 (402-ML-100, R&D Systems) in the presence of increasing concentrations of SU11652 (sc-204310 ...
-
bioRxiv - Immunology 2021Quote: ... and Rat IL-2 ELISpot Kit (R&D Systems, Cat. No.: XEL502). ELISpot plates precoated with capture antibody were blocked with LCM for at least 30 min at RT ...
-
bioRxiv - Neuroscience 2020Quote: ... 2 ng/ml Nrg1 (human NRG1-β1 extracellular domain, R&D Systems), and 2 μM forskolin ...
-
bioRxiv - Microbiology 2022Quote: ... and mouse anti-SARS-CoV-2 N monoclonal antibody (R&D systems, Clone 1035111 ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 5ng/ml IL-2(# 202-IL-050/CF, R&D Systems). Activated CD3+ T cells were isolated from Dynabead Mouse T Activator CD3/CD28 (#00775477 ...
-
bioRxiv - Bioengineering 2022Quote: ... and human fibroblast growth factor 2 (20 ng/mL, R&D Systems). hECSR was added to the bottom channel prior to addition of cells into the well ...
-
bioRxiv - Neuroscience 2020Quote: ... Recombinant human FGF-2 was purchased from R&D Systems (Minneapolis, MN).
-
bioRxiv - Cell Biology 2021Quote: ... or differentiated 10T1/2 cells were treated with LRG1 (R&D Systems) for 24 h and then treated with isoproterenol (Sigma ...
-
bioRxiv - Neuroscience 2021Quote: ... 2 mM L-glutamine and 20 ng/ml BDNF (R&D Systems). In each group (control and Celsr2 mutant) ...
-
bioRxiv - Cell Biology 2022Quote: ... 2) TGFβ2 (TGFβ2: 2.5 ng/ml; R&D Systems, Minneapolis, MN, USA) for 0-5 d followed by vehicle control (0.1% DMSO ...
-
bioRxiv - Immunology 2020Quote: ... or a combination of 2 µg/ml ICAM-1 (R&D Systems), 1 µg/ml NKp30 (R&D systems ...
-
bioRxiv - Bioengineering 2020Quote: ... Collagen gel loaded with BMP-2 (75 μg/mL, R&D Systems) was used as a positive control ...
-
bioRxiv - Molecular Biology 2021Quote: ... 0.5 ng/mL recombinant mouse IL-2(R&D system, MN, USA), and 50 μM β-mercaptoethanol (Sigma Aldrich ...
-
bioRxiv - Molecular Biology 2021Quote: ... 0.5 ng/mL recombinant mouse IL-2 (R&D system, MN, USA), and 50 μM β-mercaptoethanol (Sigma Aldrich ...
-
bioRxiv - Immunology 2020Quote: ... affinity-purified polyclonal α-human-Ace-2 antibody (R&D Systems #AF933), and recombinant human Ace-2 (R&D Systems #933-ZN-010 ...
-
bioRxiv - Immunology 2020Quote: ... Pen-Strep and human recombinant interleukin-2 (210U/mL, R&D systems). For activation ...
-
bioRxiv - Immunology 2021Quote: ... 2 nM of recombinant CHIT1 (R&D Systems. Cat # 3559-GH-010) was incubated with 20 μM substrate in McIlvain buffer (100 mM citric acid ...
-
bioRxiv - Microbiology 2022Quote: ... and 2 ug/mL of MetAP enzyme (R&D Systems 3537-ZN). Product detection,each reaction well is supplemented with 25 uL of 2 ng/mL DPPIV/CD26 (serine exopeptidase diluted in activation buffer).